Your institution may have access to this item. Find your institution then sign in to continue.
Title
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.
Authors
Yank, Veronica; Tuohy, C Vaughan; Logan, Aaron C; Bravata, Dena M; Staudenmayer, Kristan; Eisenhut, Robin; Sundaram, Vandana; McMahon, Donal; Olkin, Ingram; McDonald, Kathryn M; Owens, Douglas K; Stafford, Randall S
Abstract
Recombinant factor VIIa (rFVIIa), a hemostatic agent approved for hemophilia, is increasingly used for off-label indications.
Publication
Annals of internal medicine, 2011, Vol 154, Issue 8, p529